ANDRE ORDUNA: Open Payments
NPI 1003309451 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 13 payments from 11 companies in 2025. Trend: 2023 $258 · 2024 $486 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 2 | $46 |
| Edwards Lifesciences Corporation | 1 | $29 |
| Medtronic, Inc. | 1 | $24 |
| BridgeBio Pharma, Inc. | 1 | $23 |
| Becton, Dickinson and Company | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
| PFIZER INC. | 1 | $16 |
| CVRx, Inc. | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: SAPIEN 3 Ultra RESILIA, PENDITURE, Attruby, ARISTA, XIENCE SKYPOINT, VYNDAQEL, Barostim Neo System, CAMZYOS.
Industry payments across NE — which companies pay providers there.
